<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00841607</url>
  </required_header>
  <id_info>
    <org_study_id>18982</org_study_id>
    <nct_id>NCT00841607</nct_id>
  </id_info>
  <brief_title>Reconstruction Following Pancreaticoduodenectomy: A Randomized Clinical Trial of Pancreaticojejunostomy vs Pancreaticogastomy</brief_title>
  <official_title>Reconstruction Following Pancreaticoduodenectomy: A Randomized Clinical Trial of Pancreaticojejunostomy vs Pancreaticogastomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tom Baker Cancer Centre</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>MSI Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Calgary</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Canadian Association of General Surgeons</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Tom Baker Cancer Centre</source>
  <brief_summary>
    <textblock>
      Pancreaticoduodenectomy (PD or Whipple procedure) involves the removal of the head of the&#xD;
      pancreas and is the primary modality for treatment of peri-ampullary cancers (arising from&#xD;
      the common bile duct, Ampulla of Vater, duodenum, neuroendocrine cells of the pancreas, and&#xD;
      most commonly the exocrine pancreas). In Canada, cancer of the pancreas is the 11th cancer in&#xD;
      terms of new cases/year, and the 5th leading cause of cancer related deaths/year. Following&#xD;
      PD the remaining pancreas is re-connected to a portion of the gastrointestinal tract; the&#xD;
      pancreas is very soft and difficult to sew and connect safely. The primary cause of&#xD;
      complications following PD is related to leak occurring at this connection. Of patients that&#xD;
      develop a leak, over half need a second operation, and up to 40% will die. The two main&#xD;
      organs that the pancreas may be re-connected to are the jejunum or the stomach. The&#xD;
      investigators will compare the rates of pancreatic leakage in two groups of patients&#xD;
      randomized to reconnection to either the jejunum or stomach following PD. The goal of this&#xD;
      study is to determine which of these methods is safer. The results may change practice&#xD;
      patterns across North America and the world. It may in the future prevent many cases of&#xD;
      avoidable leakage and the resulting morbidity of this including death. This will therefore&#xD;
      reduce the morbidity and mortality of this group of cancer patients.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2006</start_date>
  <completion_date type="Actual">May 2013</completion_date>
  <primary_completion_date type="Actual">May 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>pancreatic leak/fistula</measure>
    <time_frame>Up to POD 10</time_frame>
    <description>Either a radiologically proved anastomotic leak or the continued drainage (via drain, enterocutaneous fistula, or wound) of amylase (or lipase) rich fluid on or after postoperative day 10. This is a clinically relevant definition which has been used in many other reports.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>overall morbidity</measure>
    <time_frame>Up to POD 30</time_frame>
    <description>We will use the definition and classification of complications resulting from surgery as put forth by Clavien et al which has been widely adopted in the surgical literature.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">162</enrollment>
  <condition>Pancreas Cancer</condition>
  <condition>Periampullary Cancer</condition>
  <arm_group>
    <arm_group_label>Pancreaticojejunostomy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Pancreaticojejunostomy reconstruction used following Whipple surgery.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Pancreaticogastomy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Pancreaticogastomy reconstruction used following Whipple surgery.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>pancreaticojejunostomy vs pancreaticogastrostomy</intervention_name>
    <arm_group_label>Pancreaticogastomy</arm_group_label>
    <arm_group_label>Pancreaticojejunostomy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Suspected pancreatic or periampullary neoplasm that appears to be resectable based on&#xD;
             preoperative imaging (CT scan and/or MRI) and are deemed medically fit to undergo PD.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients less than 18 years of age will be excluded.&#xD;
&#xD;
          -  As well, patients with distant metastasis, local unresectability, and/or gastric&#xD;
             involvement will be excluded.&#xD;
&#xD;
        Other exclusion criteria include:&#xD;
&#xD;
          -  female subjects who are pregnant or nursing&#xD;
&#xD;
          -  current use of an investigational drug&#xD;
&#xD;
          -  currently receiving chemotherapy or radiotherapy.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>elijah dixon, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Calgary</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Calgary</name>
      <address>
        <city>Calgary</city>
        <state>Alberta</state>
        <zip>T2N4N2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <reference>
    <citation>McKay A, Mackenzie S, Sutherland FR, Bathe OF, Doig C, Dort J, Vollmer CM Jr, Dixon E. Meta-analysis of pancreaticojejunostomy versus pancreaticogastrostomy reconstruction after pancreaticoduodenectomy. Br J Surg. 2006 Aug;93(8):929-36. Review.</citation>
    <PMID>16845693</PMID>
  </reference>
  <verification_date>October 2016</verification_date>
  <study_first_submitted>February 10, 2009</study_first_submitted>
  <study_first_submitted_qc>February 10, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 11, 2009</study_first_posted>
  <last_update_submitted>October 17, 2016</last_update_submitted>
  <last_update_submitted_qc>October 17, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 18, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Tom Baker Cancer Centre</investigator_affiliation>
    <investigator_full_name>Elijah Dixon</investigator_full_name>
    <investigator_title>Professor of Surgery, Oncology and Community Health Sciences</investigator_title>
  </responsible_party>
  <keyword>whipple</keyword>
  <keyword>pancreas</keyword>
  <keyword>reconstruction</keyword>
  <keyword>leak</keyword>
  <keyword>fistula</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pancreatic Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

